Purpose
Advance healthcare professionals' knowledge of current and future diagnostic and treatment options in von Willebrand Disease (VWD) and review current clinical research
Target Audience
This activity meets the educational needs of physicians involved in the care of patients with VWD
Program Overview
In order to properly treat and monitor patients with VWD, healthcare professionals should keep abreast of current and future diagnostic treatment options. This activity has been designed to review such options, as well as current clinical research. The following topics will be discussed:
— Clinical diagnostic algorithm for VWD/platelet dysfunction
— Sub Q DDAVP
— Use of genetics for VWD diagnosis
— Gene therapy
— Potential of recombinant VWF
Educational Objectives
Upon completion of this activity, participants should be better able to:
— Review current and emerging diagnostic tools
— Describe ongoing and advancing treatment options
— Explain recent clinical research
Credit Designation
The Postgraduate Institute for Medicine (PIM) designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential
Areas and Policies of the Accreditation Council for Continuing Medical Education
(ACCME) through the joint sponsorship of PIM and ProMed Institute. PIM is accredited by the ACCME to provide continuing medical education for physicians.
Faculty Disclosure Statement
All faculty participating in continuing education activities sponsored by the Postgraduate Institute for Medicine are expected to disclose to the audience any real or apparent commercial financial affiliations related to the content of their presentations/materials.
